Insperity (NSP) Competitors $55.49 +1.69 (+3.15%) Closing price 03:59 PM EasternExtended Trading$55.68 +0.18 (+0.33%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NSP vs. CCRN, KFY, RHI, ASGN, MAN, BBSI, HSII, KFRC, KELYA, and TBIShould you be buying Insperity stock or one of its competitors? The main competitors of Insperity include Cross Country Healthcare (CCRN), Korn/Ferry International (KFY), Robert Half (RHI), ASGN (ASGN), ManpowerGroup (MAN), Barrett Business Services (BBSI), Heidrick & Struggles International (HSII), Kforce (KFRC), Kelly Services (KELYA), and TrueBlue (TBI). Insperity vs. Its Competitors Cross Country Healthcare Korn/Ferry International Robert Half ASGN ManpowerGroup Barrett Business Services Heidrick & Struggles International Kforce Kelly Services TrueBlue Cross Country Healthcare (NASDAQ:CCRN) and Insperity (NYSE:NSP) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings. Is CCRN or NSP more profitable? Insperity has a net margin of 0.60% compared to Cross Country Healthcare's net margin of -0.70%. Insperity's return on equity of 35.32% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-0.70% 1.72% 1.24% Insperity 0.60%35.32%1.84% Do analysts rate CCRN or NSP? Cross Country Healthcare currently has a consensus target price of $17.93, suggesting a potential upside of 26.71%. Insperity has a consensus target price of $58.33, suggesting a potential upside of 5.12%. Given Cross Country Healthcare's higher possible upside, equities research analysts clearly believe Cross Country Healthcare is more favorable than Insperity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Insperity 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders & institutionals have more ownership in CCRN or NSP? 96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 93.4% of Insperity shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by company insiders. Comparatively, 5.3% of Insperity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, CCRN or NSP? Cross Country Healthcare has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Insperity has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Which has higher earnings & valuation, CCRN or NSP? Insperity has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Insperity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.34B0.34-$14.56M-$0.26-54.42Insperity$6.58B0.32$91M$1.0652.35 Does the media favor CCRN or NSP? In the previous week, Insperity had 17 more articles in the media than Cross Country Healthcare. MarketBeat recorded 18 mentions for Insperity and 1 mentions for Cross Country Healthcare. Insperity's average media sentiment score of 0.68 beat Cross Country Healthcare's score of -0.50 indicating that Insperity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Insperity 5 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryInsperity beats Cross Country Healthcare on 12 of the 15 factors compared between the two stocks. Get Insperity News Delivered to You Automatically Sign up to receive the latest news and ratings for NSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSP vs. The Competition Export to ExcelMetricInsperityStaffing IndustryBusiness SectorNYSE ExchangeMarket Cap$2.09B$1.56B$24.36B$21.17BDividend Yield4.43%3.41%2.81%3.59%P/E Ratio52.3525.9128.4529.15Price / Sales0.323.9738.8254.92Price / Cash15.018.0925.8423.84Price / Book18.683.105.925.45Net Income$91M$30.69M$197.30M$992.10M7 Day Performance8.53%4.59%1.51%2.62%1 Month Performance-6.81%-2.91%-1.45%2.51%1 Year Performance-40.13%-15.87%33.53%12.94% Insperity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPInsperity4.2991 of 5 stars$55.49+3.1%$58.33+5.1%-42.0%$2.09B$6.58B52.354,500Dividend AnnouncementCCRNCross Country Healthcare3.3584 of 5 stars$13.56+1.4%$17.93+32.2%-3.3%$438.03M$1.34B-52.158,205KFYKorn/Ferry International4.1325 of 5 stars$73.12+0.9%$81.00+10.8%+3.0%$3.79B$2.76B15.839,253News CoveragePositive NewsRHIRobert Half4.6553 of 5 stars$35.79-1.5%$45.83+28.1%-42.7%$3.70B$5.80B20.4514,700ASGNASGN3.0332 of 5 stars$52.73+1.9%$61.67+16.9%-45.3%$2.27B$4.10B16.693,200Analyst UpgradeMANManpowerGroup3.9767 of 5 stars$41.24-0.1%$48.20+16.9%-41.8%$1.91B$17.85B-108.5326,700BBSIBarrett Business Services4.2104 of 5 stars$46.41+0.8%$47.00+1.3%+32.1%$1.18B$1.14B22.863,658HSIIHeidrick & Struggles International3.0192 of 5 stars$48.65+2.1%$49.00+0.7%+30.0%$988.50M$1.12B30.602,201Positive NewsAnalyst ForecastKFRCKforce4.3964 of 5 stars$31.98-0.8%$52.33+63.6%-51.5%$594.87M$1.36B11.9312,000KELYAKelly Services4.8455 of 5 stars$14.07+0.3%$25.00+77.7%-30.2%$494.58M$4.33B-70.354,200Insider TradeTBITrueBlue4.1089 of 5 stars$6.13+6.4%$8.00+30.5%-24.5%$172.23M$1.57B-5.334,200Positive News Related Companies and Tools Related Companies CCRN Competitors KFY Competitors RHI Competitors ASGN Competitors MAN Competitors BBSI Competitors HSII Competitors KFRC Competitors KELYA Competitors TBI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSP) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insperity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insperity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access